Vesical Catheter Market Size, Share & Industry Analysis, By Product Type (Intermittent Catheter, External Catheters, Others), By Applications (Benign Prostate Hyperplasia, Urinary Incontinence, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centres, Others) and Regional Forecast, 2024-2032

A vesical catheter is a latex, silicone, or polyurethane made tube recognized as a urinary catheter that is introduced into the bladder by means of the urethra. The vesical catheter market is growing due to the increase in the incidence of enlarged prostate or bladder stones, infections in urinary tract, brain-bladder nerve problems, growing use of some medications, constipation, urethral stricture, or a weak bladder muscles. According to the National Institute of Health 2019, UTIs are the most common outpatient infections, with a lifetime incidence of 50−60% in adult women.

Vesical catheter permits the urine to deplete from the urinary bladder for collection and examination. Vesical catheter can also be used to introduce medications for treatment or diagnosis of bladder conditions. If the bladder does not completely drained, then urine can build up in the bladder and can lead to pressure in the kidneys. This increased pressure on kidneys can lead to kidney failure, which can be dangerous and result in permanent damage to the kidneys.

The increase in the incidences of urinary tract infections (UTIs), benign prostate enlargement, neurogenic bladder, urologic diseases, and lower urinary tract symptoms (LUTS) are driving the market growth. Moreover, according to the Journal of Neurology Urodynamics, the prevalence of urine retention is estimated to be 1.5% in women. In addition, favorable reimbursements and increase in the healthcare spending by the governments are also propelling the market growth.

Key Market Driver -

Increase in the incidence of urological disorders is propelling the market growth.

Key Market Restraint -

cost of urology devices and strict regulatory policies are likely to hinder the market growth

However, high cost of urology devices and strict regulatory policies for the approval of medical devices are obstructing the growth of the market.

Market Segmentation:

Globally, the vesical catheter market can be segmented on the basis of product type, applications, end-users, and region. Based on the product type, the market can be segmented into intermittent catheter, external catheters, and others. Based on the applications, the market can be segmented into benign prostate hyperplasia, urinary incontinence, others. Based on the end-users the market can be segmented into hospitals, specialty clinics, ambulatory surgical centres, and others.

Geographically, the vesical catheter market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the Vesical Catheter market are Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medicals, Teleflex Incorporated, Medtronic, Holister Incorporated, C.R. Bard., Wellspect HealthCare, and other prominent players.

Key Insights:

• Prevalence of Kidney Diseases by Key Countries/Region


• Incidence of Urinary Retention by Key Countries/ Region


• Technological Advancements by Key Countries/Region


• Introduction of New Types/Approvals (By Major Players)


• Key Industry Developments Mergers, Acquisitions, and Collaborations

Regional Analysis:

Geographically, the vesical catheter market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is estimated to hold the major share of the market and it is also projected to remain dominant in the forecast period. The market growth in this region can be ascribed to the presence of superior healthcare infrastructure and growing responsiveness towards urological diseases. Moreover, presence of key players, adoption of technologically advanced products and favorable reimbursement scenarios are also driving the market in this region. Europe is likely to be the second most rewarding market throughout the forecast period. The factors such as increasing adoption of revolutionary medical devices, increases in the incidences of urological diseases and rise in geriatric population in this region are expected to boost the growth of the vesical catheter market in this region. However, Asia-Pacific holds the largest potential for the growth of the market. The growth of the market in this region can be attributed to the presence of large patient pool, rising geriatric population. Moreover, increase in the incidences of lower urinary tract symptoms (LUTs), urinary tract infections (UTIs), and increase in the purchasing power of population in developing countries in this region are the major factors driving the growth of the market in this region. The market in Latin America and the Middle East and Africa are expected to grow reasonably in the forecast period.

To gain extensive insights into the market, Request for Customization

Segmentation

Urodynamic Systems Market Industry Developments

• In May 2017, B. Braun Melsungen AG. introduced the single-use Actreen Mini Catheter and the Actreen Mini Set at the American Urological Association (AUA) annual conference in Boston.


• In February 2017, Cook Medical introduced Universa line with the introduction of two new sets for percutaneous urinary drainage.